Queen Sonja about Mette-Marit: "It was fantastic"

On June 20, 2026, Norway's Crown Princess Mette-Marit underwent a successful lung transplant following years of battling a chronic illness. The procedure marked a significant milestone in her health journey, as she had been suffering from pulmonary fibrosis since 2018. Her condition had deteriorated over the past months, leading to her being placed on the waiting list for a transplant on May 5, 2026. The surgery took place on Wednesday, and reports indicate that the operation was completed without complications.

The first official comment on the transplant came from Queen Sonja, who expressed her admiration for Mette-Marit’s resilience and recovery. In an interview with Norwegian Broadcasting Corporation (NRK), Queen Sonja described the situation as "fantastic" and emphasized how remarkable it was that the operation had gone so well. This statement reflects the deep respect and concern within the royal family for Mette-Marit’s health and well-being. Queen Sonja has long been known for her supportive role in the royal household, often stepping forward during times of crisis or celebration.

Crown Princess Mette-Marit, alongside Crown Prince Haakon and Queen Sonja, participated in the annual May 17th celebrations earlier this year. These festivities, which mark Norway's Constitution Day, were attended by members of the royal family and citizens alike. At the time, there were no visible signs of Mette-Marit’s declining health, highlighting the suddenness of her recent medical challenges. Her presence at these events underscored her active role in public life before her health necessitated more private treatment.

The decision to proceed with the lung transplant was made after careful consideration by medical professionals. According to reports, Mette-Marit had been under close observation for several months, with doctors monitoring her condition as it worsened. The waitlist process involves rigorous evaluations to ensure compatibility between donor and recipient, and once a suitable match was found, the surgery was scheduled promptly. The success of such procedures relies heavily on both the expertise of the medical team and the patient’s overall health status prior to the operation.

Medical experts have noted that while lung transplants carry inherent risks, including rejection and infection, the outcome in Mette-Marit’s case appears promising. Dr. Johan Styrud, one of the lead surgeons involved in the procedure, spoke about the importance of post-operative care and the need for continued monitoring. His comments, shared with Swedish Television (SVT), emphasized the complexity of the surgery but also the optimism surrounding the princess’s recovery. He highlighted the significance of early intervention and the advancements in transplant medicine that have improved survival rates over the years.

Reactions from the public and media have been largely positive, reflecting widespread support for the crown princess. Social media platforms saw an outpouring of messages wishing her a swift recovery, while many outlets focused on the emotional impact of her illness and subsequent treatment. The transparency shown by the royal family regarding Mette-Marit’s health has been praised, with some observers noting that it sets a precedent for openness in matters of public interest.

Looking ahead, the focus will remain on Mette-Marit’s rehabilitation and long-term health management. Medical teams will continue to monitor her progress closely, ensuring that she adapts well to her new lungs. As for the royal family, they are expected to maintain their public engagements while allowing Mette-Marit the necessary time to recover privately. The incident serves as a reminder of the fragility of health and the strength required to face serious medical conditions, particularly when they affect individuals in prominent positions.